SCHEMBL7002284

SCHEMBL7002284

COc1ccc(C2C[C@H]2C(=O)O)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
CA12 O43570 1/20 0.55
PDE4B Q07343 4/20 0.52
PDE4A P27815 2/20 0.52
PDE4C Q08493 2/20 0.52
PDE4D Q08499 2/20 0.52
NR3C1 P04150 2/20 0.50
TRPM5 Q9NZQ8 2/20 0.49
KMT2A Q03164 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
FFAR1 O14842 2/20 0.48
TUBB4A P04350 2/20 0.47
TUBB P07437 2/20 0.47
TUBA3C P0DPH7 2/20 0.47
TUBA1B P68363 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002288 1.00 APP (0.55) APPCA1CA2CA9CA12
SCHEMBL2952559 1.00 APP (0.55) APPCA1CA2CA9CA12
SCHEMBL7003488 0.88 RXRA (0.49) APPCA1CA2CA9CA12
SCHEMBL10254282 0.88 RXRA (0.49) APPCA1CA2CA9CA12
SCHEMBL7002924 0.88 RXRA (0.49) APPCA1CA2CA9CA12
SCHEMBL13001927 0.87 PDE4B (0.52) APPPDE4BPDE4APDE4CPDE4D
SCHEMBL22714051 0.86 PDE4B (0.58) APPCA1CA2CA9CA12
SCHEMBL7366496 0.86 PDE4B (0.70) PDE4BPDE4APDE4CPDE4D
SCHEMBL7366497 0.86 PDE4B (0.70) PDE4BPDE4APDE4CPDE4D
SCHEMBL6996736 0.86 ALDH1A1 (0.52) APPCA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed